Basic Information
Teva Respiratory, a subsidiary of Teva Pharmaceutical Industries, has launched two new products: AirDuo Digihaler and ArmonAir Digihaler, further enhancing its digital inhaler portfolio. Both new inhalers are prescription powder inhalers designed to treat asthma patients aged 12 years and older. AirDuo is used to control asthma symptoms and prevent conditions such as wheezing, while ArmonAir is intended for the long-term treatment of asthma.
Teva Respiratory, LLC
United States of America
unclear
January 01, 2020
--
--

